TLRs in other indications

Chronoinflammaging in Alzheimer; A systematic review on the roles of toll like receptor 2.
Ravari A, Mirzaei T, Kennedy D, Arababadi MK.
Life Sci. 2017 Jan 10. pii: S0024-3205(17)30003-6.

Toll-like receptor 2 is increased in neurons in Parkinson's disease brain and may contribute to alpha-synuclein pathology.
Dzamko N, Gysbers A, Perera G, Bahar A, Shankar A, Gao J, Fu Y, Halliday GM.
Acta Neuropathol. 2017 Feb;133(2):303-319.

The Role of TLR2, TLR4, and TLR9 in the Pathogenesis of Atherosclerosis.
Roshan MH, Tambo A, Pace NP.
Int J Inflam. 2016;2016:1532832..

A Decade of Research on TLR2 Discovering Its Pivotal Role in Glial Activation and Neuroinflammation in Neurodegenerative Diseases
Hayward JH, Lee SJ. Exp
Neurobiol. 2014 Jun;23(2):138-47

Inflammation and acne: putting the pieces together.
Harvey A, Huynh TT.
J Drugs Dermatol. 2014 Apr;13(4):459-63.

Toll-like receptors signaling in glomerular diseases.
Mao S, Huang S.
J Recept Signal Transduct Res. 2014 Apr;34(2):81-4.

Toll-like receptors: sensing and reacting to diabetic injury in the kidney.
Lin M, Tang SC.
Nephrol Dial Transplant. 2014 Apr;29(4):746-54.

Toll-like receptors and liver disease.
Kesar V, Odin JA.
Liver Int. 2014 Feb;34(2):184-96.

The role of Toll-like receptors in multiple sclerosis and possible targeting for therapeutic purposes.
Gooshe M, Abdolghaffari AH, Gambuzza ME, Rezaei N.
Rev Neurosci. 2014;25(5):713-39.

Toll-like receptor polymorphisms and rheumatoid arthritis: a systematic review.
Lee YH, Bae SC, Kim JH, Song GG.
Rheumatol Int. 2014 Jan;34(1):111-6.